Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
Stephen R. Morairty, Florent G. Revel, Pari Malherbe, et al.
PLoS ONE (2012) Vol. 7, Iss. 7, pp. e39131-e39131
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Circadian rhythm as a therapeutic target
Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 287-307
Open Access | Times Cited: 293
The Neurobiology of Sleep and Wakefulness
Michael D. Schwartz, Thomas S. Kilduff
Psychiatric Clinics of North America (2015) Vol. 38, Iss. 4, pp. 615-644
Open Access | Times Cited: 172
Orexin neurons suppress narcolepsy via 2 distinct efferent pathways
Emi Hasegawa, Masashi Yanagisawa, Takeshi Sakurai, et al.
Journal of Clinical Investigation (2014) Vol. 124, Iss. 2, pp. 604-616
Open Access | Times Cited: 157
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
A role for cortical nNOS/NK1 neurons in coupling homeostatic sleep drive to EEG slow wave activity
Stephen R. Morairty, Lars Dittrich, Ravi K. Pasumarthi, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 50, pp. 20272-20277
Open Access | Times Cited: 124
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Carsten T. Beuckmann, Michiyuki Suzuki, Takashi Ueno, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 2, pp. 287-295
Open Access | Times Cited: 89
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation
Jasbir S. Dalal, Jee Hoon Roh, Susan E. Maloney, et al.
Genes & Development (2013) Vol. 27, Iss. 5, pp. 565-578
Open Access | Times Cited: 100
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 19, pp. 7590-7607
Closed Access | Times Cited: 98
Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders
Michihiro Mieda, Takeshi Sakurai
CNS Drugs (2013) Vol. 27, Iss. 2, pp. 83-90
Closed Access | Times Cited: 98
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner, et al.
BMC Neuroscience (2013) Vol. 14, Iss. 1
Open Access | Times Cited: 88
Discovery and Characterization of ACT‐335827, an Orally Available, Brain Penetrant Orexin Receptor Type 1 Selective Antagonist
Michel A. Steiner, John Gatfield, Catherine Brisbare‐Roch, et al.
ChemMedChem (2013) Vol. 8, Iss. 6, pp. 898-903
Closed Access | Times Cited: 87
An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Kayla Janto, J. Roxanne Prichard, Snigdha Pusalavidyasagar
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 08, pp. 1399-1408
Open Access | Times Cited: 81
Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1
Courtney D. Prince, Andrew R. Rau, Jordan T. Yorgason, et al.
ACS Chemical Neuroscience (2014) Vol. 6, Iss. 1, pp. 138-146
Open Access | Times Cited: 80
Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities
Oliviero Bruni, Marco Angriman, Fabrizio Calisti, et al.
Journal of Child Psychology and Psychiatry (2017) Vol. 59, Iss. 5, pp. 489-508
Open Access | Times Cited: 77
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 11, pp. 4648-4664
Closed Access | Times Cited: 76
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
The roles of orexins in sleep/wake regulation
Michihiro Mieda
Neuroscience Research (2017) Vol. 118, pp. 56-65
Open Access | Times Cited: 73
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 72
Orexin Receptor Antagonism Improves Sleep and Reduces Seizures inKcna1-null Mice
Harrison M. Roundtree, Timothy A. Simeone, Chaz Johnson, et al.
SLEEP (2016) Vol. 39, Iss. 2, pp. 357-368
Open Access | Times Cited: 68
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top